Antimetastatic effect of fluvastatin on breast and hepatocellular carcinoma cells in relation to SGK1 and NDRG1 genes
Authors:
- 29 September 2015
- journal article
- Published by Springer Nature in Tumor Biology
- Vol. 37 (3) , 3017-3024
Abstract
Metastasis occurs due to migration of the cells from primary tumor toward other tissues by gaining invasive properties. Since metastatic invasion shows a strong resistance against conventional cancer treatments, the studies on this issue have been focused. Within this context, inhibition of migration and determination of the relationships at the gene level will contribute to treatment of metastatic cancer cases. We have aimed to demonstrate the impact of TGF-β1 and fluvastatin on human breast cancer (MCF-7) and human hepatocellular carcinoma (Hep3B) cell cultures via Real-Time Cell Analyzer (RTCA) and to test the expression levels of some genes (NDRG1, SGK1, TWIST1, AMPKA2) and to compare their gene expression levels according to RTCA results. Both of cell series were applied TGF-β1 and combinations of TGF-β1/fluvastatin. Primer and probes were synthesized using Universal Probe Library (UPL, Roche) software, and expression levels of genes were tested via qPCR using the device LightCycler 480 II (Roche). Consequently, fluvastatin dose-dependently inhibited migration induced by TGF-β1 in both groups. This inhibition was accompanied by low level of SGK1 messenger RNA (mRNA) and high levels of NDRG1 and AMPKA2 mRNA. Thus, we conclude that fluvastatin plays an important role in reducing resistance to chemotherapeutics and preventing metastasis.Keywords
This publication has 41 references indexed in Scilit:
- Significance of SGK1 in the regulation of neuronal functionThe Journal of Physiology, 2010
- The therapeutic promise of the cancer stem cell conceptJournal of Clinical Investigation, 2010
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- AMP-activated protein kinase adapts rRNA synthesis to cellular energy supplyProceedings of the National Academy of Sciences, 2009
- The physiological impact of the serum and glucocorticoid-inducible kinase SGK1Current Opinion in Nephrology and Hypertension, 2009
- Biomarkers for epithelial-mesenchymal transitionsJournal of Clinical Investigation, 2009
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- Transforming growth factor-β in cancer and metastasisCancer and Metastasis Reviews, 2006
- HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosisLeukemia, 2002
- Role of AMP-activated protein kinase in mechanism of metformin actionJournal of Clinical Investigation, 2001